| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030979 |
| Receipt No. | R000035374 |
| Official scientific title of the study | Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue |
| Date of disclosure of the study information | 2018/01/29 |
| Last modified on | 2018/07/11 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue | |
| Title of the study (Brief title) | Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue | |
| Region |
|
|
| Condition | ||
| Condition | Healthy subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine an effect of a test food product on reliving a feeling of fatigue after an exercise stress test by selecting those who are aged 30 and over, below 45 and have no exercise habit and assigning them to take the test food product for 1 week on a continuous basis. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | VAS, Creatine kinase, Lactic acid |
| Key secondary outcomes | Hematologic test, blood biochemical test, vital signs |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1-week intake of the test food
Wash out 1-week intake of the placebo |
|
| Interventions/Control_2 | 1-week intake of the placebo
Wash out 1-week intake of the test food |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Age: 30 and over, below 45
2)Sex: Males and females with Japanese nationality 3)No exercise habit in the last 12 months *Those who exercise once a week or less, or 2 to 3 times a month will be accepted. |
|||
| Key exclusion criteria | 1)Currently in treatment with medication or seeing a doctor for treatment
2)Previous history of hepatic disorder or severe disorder related to kidney, endocrine, cardiovascular system, gastro-intestine, lung, blood, or metabolism, or currently presence of complications 3)Previous history of drug allergy or food allergy 4)Regular intake of a food product or a supplement with a possible effect on relieving fatigue 5)Regular intake of medication with a possible effect on relieving fatigue 6)Extreme faddiness 7)Extremely irregular lifestyle such as a dietary pattern and a sleeping pattern 8)Sleep disorder(insomnia, sleep apnea syndrome; SAS, etc.) 9)Presence or previous history of mental disorder (depression, etc.) 10)Presence or previous history of alcoholism 11)Current participation in another clinical trial or participation in another clinical trial within the last three months 12)Irregular work hours such as working on night shift 13)Exercise habit (twice a week or more) 14)Determined by the investigator to be unsuitable for enrollment in this study |
|||
| Target sample size | 26 | |||
| Research contact person | |
| Name of lead principal investigator | Takihara Takanobu |
| Organization | ITO EN, Ltd. |
| Division name | Central Research Institute |
| Address | 21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan |
| TEL | 0548-54-1247 |
| t-takihara@itoen.co.jp | |
| Public contact | |
| Name of contact person | Ochitani Daisuke |
| Organization | HUMA R&D CORP |
| Division name | Clinical Development Division |
| Address | Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan |
| TEL | 81-3-3431-1260 |
| Homepage URL | |
| ochitani@huma-c.co.jp | |
| Sponsor | |
| Institute | HUMA R&D CORP |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ITO EN, LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035374 |